Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
PODC$2.14+0.34(+18.62%)PodcastOne (NASDAQ:PODC) Board of Directors Forms Special Committee and Intends to Retain Financial Advisor Following Inbound Strategic Interest[11:00:00 AM ET]III$6.02-0.07(-1.15%)Deloitte is named a Leader in the ISG Provider Lens™: Workday Ecosystem Services 2026 for the fourth time in the US and Europe and the second time in APAC Deloitte has been recognized as a Leader in the ISG Provider Lens™: Workday Ecosystem Services 2026 study across the United States, Europe, and Asia...[11:00:00 AM ET]MWYN$2.40+0.17(+7.48%)Marwynn Holdings Signs Non-Binding MOU with Grenada National Resort to Evaluate Solar-Powered AI Data Center Campus[11:00:00 AM ET]ADSK$242.07-0.03(-0.01%)Autodesk named a Leader in the IDC MarketScape: Worldwide Construction Management Software 2026 Vendor Assessment Autodesk, Inc. (NASDAQ: ADSK) today announced that IDC MarketScape has positioned the company in the Leaders Category of the inaugural IDC...[11:00:00 AM ET]HEINY$43.40+0.61(+1.42%)Europe’s Living Rooms: HEINEKEN and Magnum Photos Release Photoseries Documenting Europe’s Pubs and Bars[10:54:49 AM ET]EQNR$47.74+0.67(+1.43%)Notifiable trading – Equinor ASA[10:34:32 AM ET]NIDB$24.60+0.04(+0.16%)NORTHEAST INDIANA BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS Northeast Indiana Bancorp, Inc., (OTCQB: NIDB), the parent company of First Federal Savings Bank, today announced net income of $1,991,000 ($0.85 per ...[10:34:00 AM ET]FFWC$53.170.00(0.00%)FFW Corporation Announces Earnings for the Quarter Ended September 30, 2026[10:33:15 AM ET]NXST$164.31-1.95(-1.17%)TEGNA Taps Brian Gregory to lead North Carolina Stations WCNC and WFMY[10:30:00 AM ET]GWW$1,343.56+0.84(+0.06%)GRAINGER DECLARES QUARTERLY DIVIDEND W.W. Grainger, Inc. (NYSE: GWW) announced today that its board of directors approved a quarterly cash dividend of $2.49 per share. The dividend is...[10:30:00 AM ET]NTDOY$13.03-0.19(-1.44%)New Indie World Showcase Features Cozy and Chaotic Fun for Nintendo Switch 2 and Nintendo Switch[10:30:00 AM ET]

BLCO · NYSE

Bausch + Lomb Corporation

$19.36 +1.76 (+10.00%)

Company overview

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lenses covering the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions such as eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Market cap
$6.9B
Employees
13,500
Headquarters
Vaughan, ON
Website
bausch.com
CEO
Brenton L. Saunders
Listed
May 6, 2022
P/E
-31.31
Dividend yield
0.00%

Company financials

Revenue
$5.2B
Gross profit
$2.9B
Operating income
$308M
EBITDA
$724M
Net income
-$219M
EPS
-$0.62
Total assets
$13.8B
Total debt
$39M
Gross margin
55.86%
Net margin
-4.21%
Earnings yield
-3.19%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

14.5015.5316.5617.5918.62
BLCO 1D NYSE O17.43H17.76L17.32C17.60+0.02 (+0.11%)Vol103.65K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
BLCOBausch + Lomb Corporation Stock news Bausch + Lomb (BLCO) Surpasses Q3 Earnings and Revenue Estimates Zacks Investment Research
BLCOBausch + Lomb Corporation Press release Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance Business Wire
BLCOBausch + Lomb Corporation Press release Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28 Business Wire
BLCOBausch + Lomb Corporation Stock news Head to Head Survey: Bausch + Lomb (NYSE:BLCO) vs. Terumo (OTCMKTS:TRUMY) Defense World
BLCOBausch + Lomb Corporation Stock news Financial Survey: Merit Medical Systems (NASDAQ:MMSI) vs. Bausch + Lomb (NYSE:BLCO) Defense World
BLCOBausch + Lomb Corporation Stock news BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser Zacks Investment Research
BLCOBausch + Lomb Corporation Press release Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser Business Wire
BLCOBausch + Lomb Corporation Stock news Bausch + Lomb Advances Two First-in-Class Eye Health Therapies Zacks Investment Research
BLCOBausch + Lomb Corporation Stock news Bausch + Lomb Corporation (BLCO) Discusses Results and Development Plans for Dual Action Dry Eye Medicine and Lead Ocular Surface Pain Candidate Transcript Seeking Alpha
BLCOBausch + Lomb Corporation Stock news Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib Goal MarketBeat
BLCOBausch + Lomb Corporation Press release Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results Business Wire
AEP Stock news Carl Icahn Trims JetBlue, AEP Stakes While Sitting Out New Stock Bets Benzinga
BLCOBausch + Lomb Corporation Stock news Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000 Fool - Investing News
BLCOBausch + Lomb Corporation Press release Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board PRNewsWire
BLCOBausch + Lomb Corporation Press release Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance Business Wire
BLCOBausch + Lomb Corporation Stock news Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S. Zacks Investment Research
BLCOBausch + Lomb Corporation Press release Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate Business Wire
BLCOBausch + Lomb Corporation Press release Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care Business Wire
BLCOBausch + Lomb Corporation Press release Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29 Business Wire
BLCOBausch + Lomb Corporation Press release New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence Business Wire
See more
FAQ

Questions about Bausch + Lomb Corporation

What does Bausch + Lomb Corporation do?
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lenses covering the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions such as eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use.
What is BLCO's market cap?
Bausch + Lomb Corporation (BLCO) is a listed stock with a live quote. The latest market cap on this page is $6.9B.
Where is Bausch + Lomb Corporation headquartered?
Bausch + Lomb Corporation is headquartered in Vaughan, ON.
How do I get BLCO news from the API?
Call GET /v1/news?tickers=BLCO. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does BLCO news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for BLCO, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the BLCO price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs